Disparities in statin use following identification of coronary artery calcium
- PMID: 40290415
- PMCID: PMC12022484
- DOI: 10.1016/j.ajpc.2025.100990
Disparities in statin use following identification of coronary artery calcium
Abstract
Background: Coronary artery calcium (CAC) scoring is a useful tool for risk stratification in asymptomatic individuals, and current clinical practice is to utilize statins in individuals with CAC. A growing body of research has aimed to identify and mitigate health disparities and their relation to cardiovascular disease (CVD) risk. Likewise, studies have highlighted social determinants of health (SDOH) that contribute to health disparities in CVD.
Objectives: We aimed to evaluate whether disparities exist with regards to statin use after identification of CAC within the Multi-Ethnic Study of Atherosclerosis (MESA).
Methods: The associations between race/ethnicity, age, sex, primary language, and an aggregate SDOH score (calculated using previously defined methods) with statin use at short- and long-term follow-up were evaluated in logistic regression models with adjustment for traditional CVD risk factors in individuals with baseline CAC>0 without baseline statin use.
Results: In the overall cohort, 3416 participants had CAC = 0, 1794 CAC 1-99, 757 CAC 100-300, and 847 CAC>300 AU Mean age was 62 (10.2) years, 53 % (n = 3601) were women, 38.5 % (n = 2622) were non-Hispanic White, 27.8 % (n = 1892) were non-Hispanic Black, 22.0 % (n = 1892) were Hispanic and 11.8 % (n = 1892) were Chinese. At short-term follow up (median 1.6 years, n = 2665), those with a higher SDOH score (worse burden) (OR 0.39, 95 % CI 0.16-0.91), Hispanic (OR 0.59, 95 % CI 0.40-0.85) and Spanish speaking individuals (OR 0.51, 95 % CI 0.30-0.83) were less likely to report statin use following CAC identification. At long-term follow up (median 9.4 years, n = 2533), Black individuals (OR 0.71, 95 % CI 0.52-0.96), Chinese (OR 0.58, 95 % CI 0.39-0.86) and Chinese speaking individuals (OR 0.50, 95 % CI 0.33-0.76) were also less likely to report statin use following CAC identification, and a trend was noted for SDOH score (OR 0.53, 95 % CI 0.26-1.09).
Conclusions: This study identifies disparities in statin use by race/ethnicity, language, and social determinants of health after identification of CAC. While CAC is an effective tool for identifying atherosclerosis in asymptomatic individuals, more equitable use of subsequent therapy is needed.
Keywords: Coronary artery calcium; Disparities; Statin.
© 2025 The Author(s).
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Harpreet S. Bhatia reports financial support was provided by National Institutes of Health. H.S.B - consultant / advisor for Kaneka, Novartis, Abbott, Arrowhead; editorial board for AJPC M.D.S - supported by institutional grants from Amgen, Arrowhead, Boehringer Ingelheim, 89Bio, Esperion, Novartis, Ionis, Merck, and New Amsterdam. He has participated in Scientific Advisory Boards with Amgen, Agepha, Ionis, Novartis, New Amsterdam, and Merck. He has served as a consultant for Ionis, Novartis, Regeneron, Aidoc, Shanghai Pharma Biotherapeutics, Kaneka, Novo Nordisk, Arrowhead, and Tourmaline. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.JAMA Cardiol. 2021 Oct 1;6(10):1161-1170. doi: 10.1001/jamacardio.2021.2321. JAMA Cardiol. 2021. PMID: 34259820 Free PMC article.
-
Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium.Circulation. 2006 Feb 7;113(5):647-56. doi: 10.1161/CIRCULATIONAHA.105.552737. Circulation. 2006. PMID: 16461837
-
Cost-effectiveness of coronary artery calcium testing for coronary heart and cardiovascular disease risk prediction to guide statin allocation: the Multi-Ethnic Study of Atherosclerosis (MESA).PLoS One. 2015 Mar 18;10(3):e0116377. doi: 10.1371/journal.pone.0116377. eCollection 2015. PLoS One. 2015. PMID: 25786208 Free PMC article.
-
Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.JAMA Cardiol. 2017 Dec 1;2(12):1332-1340. doi: 10.1001/jamacardio.2017.4191. JAMA Cardiol. 2017. PMID: 29117273 Free PMC article.
-
Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium.Atherosclerosis. 2021 Jan;316:79-83. doi: 10.1016/j.atherosclerosis.2020.10.009. Epub 2020 Oct 10. Atherosclerosis. 2021. PMID: 33121743 Free PMC article.
References
-
- Frank D.A., Johnson A.E., Hausmann L.R.M., Gellad W.F., Roberts E.T., Vajravelu R.K. Disparities in guideline-recommended statin use for prevention of atherosclerotic cardiovascular disease by race, ethnicity, and gender A nationally representative cross-sectional analysis of adults in the United States. Ann Intern Med. 2023;176(8):1057–1066. doi: 10.7326/M23-0720. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources